Latest news with #USDNotes
Yahoo
6 hours ago
- Business
- Yahoo
Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
WALLINGFORD, Conn., June 09, 2025--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) (the "Company") announced today the pricing of its offering of $750 million aggregate principal amount of senior notes due 2028 (the "USD Notes"). The USD Notes will have an interest rate of 4.375% per annum. The closing of the offering of USD Notes (the "USD Notes Offering") is expected to occur on June 12, 2025, subject to the satisfaction of customary closing conditions. Substantially concurrently with or shortly after the USD Notes Offering, the Company expects to offer, by means of a separate prospectus supplement, euro-denominated notes (the "Euro Notes"). Neither the completion of the USD Notes Offering nor the offering of the Euro Notes (the "Euro Notes Offering") is contingent on the completion of the other. Therefore, it is possible that the USD Notes Offering is completed and the Euro Notes Offering is not completed. The Company intends to use the net proceeds from the USD Notes Offering and the Euro Notes Offering to repay borrowings under the Company's U.S. commercial paper program and for general corporate purposes. Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC are serving as the joint book-running managers for the USD Notes Offering. The USD Notes are being offered pursuant to the Company's effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"). A prospectus supplement describing the terms of this offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the offering may be obtained from Citigroup Global Markets Inc. toll-free at 1-800-831-9146, Mizuho Securities USA LLC toll-free at 1-866-271-7403 and TD Securities (USA) LLC toll-free at 1-855-495-9846. This press release does not constitute an offer to sell or the solicitation of an offer to buy the USD Notes, nor will there be any sale of the USD Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the USD Notes will be made only by means of the prospectus supplement and the accompanying prospectus. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit Forward-Looking Statements Statements in this press release which are other than historical facts are intended to be "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect our operating and financial performance can be found in the Company's latest Annual Report on Form 10-K and the Company's subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law. View source version on Contacts Sherri ScribnerVice President, Strategy and Investor Relations203-265-8820IR@
Business Wire
6 hours ago
- Business
- Business Wire
Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
WALLINGFORD, Conn.--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) (the 'Company') announced today the pricing of its offering of $750 million aggregate principal amount of senior notes due 2028 (the 'USD Notes'). The USD Notes will have an interest rate of 4.375% per annum. The closing of the offering of USD Notes (the 'USD Notes Offering') is expected to occur on June 12, 2025, subject to the satisfaction of customary closing conditions. Substantially concurrently with or shortly after the USD Notes Offering, the Company expects to offer, by means of a separate prospectus supplement, euro-denominated notes (the 'Euro Notes'). Neither the completion of the USD Notes Offering nor the offering of the Euro Notes (the 'Euro Notes Offering') is contingent on the completion of the other. Therefore, it is possible that the USD Notes Offering is completed and the Euro Notes Offering is not completed. The Company intends to use the net proceeds from the USD Notes Offering and the Euro Notes Offering to repay borrowings under the Company's U.S. commercial paper program and for general corporate purposes. Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC are serving as the joint book-running managers for the USD Notes Offering. The USD Notes are being offered pursuant to the Company's effective shelf registration statement on file with the Securities and Exchange Commission (the 'SEC'). A prospectus supplement describing the terms of this offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the offering may be obtained from Citigroup Global Markets Inc. toll-free at 1-800-831-9146, Mizuho Securities USA LLC toll-free at 1-866-271-7403 and TD Securities (USA) LLC toll-free at 1-855-495-9846. This press release does not constitute an offer to sell or the solicitation of an offer to buy the USD Notes, nor will there be any sale of the USD Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the USD Notes will be made only by means of the prospectus supplement and the accompanying prospectus. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit Forward-Looking Statements Statements in this press release which are other than historical facts are intended to be 'forward-looking statements' within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect our operating and financial performance can be found in the Company's latest Annual Report on Form 10-K and the Company's subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law.
Yahoo
6 hours ago
- Business
- Yahoo
Amphenol Corporation Announces Pricing of USD-Denominated Senior Notes Offering
WALLINGFORD, Conn., June 09, 2025--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) (the "Company") announced today the pricing of its offering of $750 million aggregate principal amount of senior notes due 2028 (the "USD Notes"). The USD Notes will have an interest rate of 4.375% per annum. The closing of the offering of USD Notes (the "USD Notes Offering") is expected to occur on June 12, 2025, subject to the satisfaction of customary closing conditions. Substantially concurrently with or shortly after the USD Notes Offering, the Company expects to offer, by means of a separate prospectus supplement, euro-denominated notes (the "Euro Notes"). Neither the completion of the USD Notes Offering nor the offering of the Euro Notes (the "Euro Notes Offering") is contingent on the completion of the other. Therefore, it is possible that the USD Notes Offering is completed and the Euro Notes Offering is not completed. The Company intends to use the net proceeds from the USD Notes Offering and the Euro Notes Offering to repay borrowings under the Company's U.S. commercial paper program and for general corporate purposes. Citigroup Global Markets Inc., Mizuho Securities USA LLC and TD Securities (USA) LLC are serving as the joint book-running managers for the USD Notes Offering. The USD Notes are being offered pursuant to the Company's effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"). A prospectus supplement describing the terms of this offering will be filed with the SEC. Copies of the prospectus supplement and accompanying prospectus for the offering may be obtained from Citigroup Global Markets Inc. toll-free at 1-800-831-9146, Mizuho Securities USA LLC toll-free at 1-866-271-7403 and TD Securities (USA) LLC toll-free at 1-855-495-9846. This press release does not constitute an offer to sell or the solicitation of an offer to buy the USD Notes, nor will there be any sale of the USD Notes, in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any offer, solicitation or sale of the USD Notes will be made only by means of the prospectus supplement and the accompanying prospectus. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 countries around the world and sells its products through its own global sales force, independent representatives and a global network of electronics distributors. Amphenol has a diversified presence as a leader in high-growth areas of the interconnect market including: Automotive, Commercial Aerospace, Communications Networks, Defense, Industrial, Information Technology and Data Communications and Mobile Devices. For more information, visit Forward-Looking Statements Statements in this press release which are other than historical facts are intended to be "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, the Private Securities Litigation Reform Act of 1995 and other related laws. While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated. Details regarding various significant risks and uncertainties that may affect our operating and financial performance can be found in the Company's latest Annual Report on Form 10-K and the Company's subsequent filings with the Securities and Exchange Commission, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. In providing forward-looking statements, the Company is not undertaking any duty or obligation to update these statements publicly as a result of new information, future events or otherwise, except as required by law. View source version on Contacts Sherri ScribnerVice President, Strategy and Investor Relations203-265-8820IR@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-03-2025
- Business
- Yahoo
Celanese Corporation Upsizes and Prices $2.6 Billion Senior Unsecured Notes Offering
DALLAS, March 07, 2025--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE) (the "Company" or "Celanese"), a global chemical and specialty materials company, today announced that its subsidiary, Celanese US Holdings LLC (the "Issuer"), has priced registered offerings (the "Offering") of $2.6 billion aggregate principal amount of notes, including $700 million aggregate principal amount of 6.500% Senior Notes due 2030, $1.1 billion aggregate principal amount of 6.750% Senior Notes due 2033 (together, the "USD Notes") and €750 million (or approximately $810 million) aggregate principal amount of 5.000% Senior Notes due 2031 (the "Euro Notes" and, together with the USD Notes, the "Notes"). The Offering was upsized from $2.0 billion to $2.6 billion aggregate principal amount of Notes. The Notes will be guaranteed on a senior unsecured basis by the Company and certain of the Company's wholly-owned domestic subsidiaries. The Offering is expected to close on or about March 14, 2025. The net proceeds from the Offering, together with borrowings under the Company's 364-day term loan credit agreement, will be used to fund previously announced cash tender offers for a portion of the Issuer's outstanding 4.777% Senior Notes due 2026 and a portion of the Issuer's outstanding 6.165% Senior Notes due 2027, to repay a portion of the Company's outstanding borrowings under its five-year term loan credit agreement due 2027, to repay borrowings under the Company's revolving credit facility due 2027, to repay the Issuer's outstanding 6.050% Senior Notes due March 15, 2025, and for general corporate purposes, which may include the repayment of other outstanding indebtedness. "This Offering reinforces our commitment to proactively manage our debt maturity profile by aligning near-term maturities to a conservative outlook for free cash flow generation and divestiture proceeds while maintaining additional flexibility through prepayable debt," said Chuck Kyrish, Senior Vice President and Chief Financial Officer. "We will provide a more comprehensive summary of the impact of this Offering and other associated transactions at completion in the coming weeks. In the future as we look out to 2027 and beyond, we will continue to balance being opportunistic and prudent in managing our debt maturity profile." J.P. Morgan, BofA Securities, HSBC, Citigroup, Deutsche Bank Securities Inc., TD Securities, Truist, Goldman Sachs & Co. LLC and US Bancorp are acting as Joint Book-Running Managers for the offering of USD Notes. J.P. Morgan, Citigroup, Deutsche Bank Securities Inc., BofA Securities, HSBC, MUFG, UniCredit, PNC Capital Markets LLC and SMBC are acting as Joint Book-Running Managers for the offering of Euro Notes. When available, a copy of the preliminary prospectus supplement for the USD Notes, the preliminary prospectus supplement for the Euro Notes and the accompanying base prospectus may be obtained by calling J.P. Morgan Securities plc (for non-U.S. investors) at +44 207-134-2468 or J.P. Morgan Securities LLC (for U.S. investors) at 1-212-834-4533 (collect). An electronic copy of the preliminary prospectus supplements and the accompanying base prospectus may also be obtained at no charge at the Securities and Exchange Commission's website at This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The Offering may be made only by means of a prospectus and prospectus supplement meeting the requirements of Section 10 of the Securities Act of 1933, as amended. The Offering will be made pursuant to an effective shelf registration statement, which was previously filed by Celanese with the Securities and Exchange Commission, and a prospectus supplement for the USD Notes, a prospectus supplement for the Euro Notes and the accompanying prospectus, which will be filed by Celanese with the Securities and Exchange Commission. About Celanese Celanese is a global leader in chemistry, producing specialty material solutions used across most major industries and consumer applications. Our businesses use our chemistry, technology and commercial expertise to create value for our customers, employees and shareholders. We support sustainability by responsibly managing the materials we create and growing our portfolio of sustainable products to meet customer and societal demand. We strive to make a positive impact in our communities and to foster inclusivity across our teams. Celanese is a Fortune 500 company that employs approximately 12,200 employees worldwide with 2024 net sales of $10.3 billion. Forward-Looking Statements: This release may contain "forward-looking statements," which include information concerning the Offering, and the Company's plans, objectives, goals, strategies, future revenues, cash flow, synergies, performance, capital expenditures and other information that is not historical information. When used in this release, the words "outlook," "forecast," "estimates," "expects," "anticipates," "projects," "plans," "intends," "believes," "will" and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied by the forward-looking statements contained in this release. These include the successful closing of the Offering, the successful completion of the concurrent tender offers referenced herein, and other information that is not historical information. Numerous other factors, many of which are beyond the Company's control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the Company's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. View source version on Contacts Celanese Contacts: Investor RelationsWilliam Cunningham+1 302 772 Media Relations – GlobalJamaison Schuler+1 972 443 4400media@ Media Relations Europe (Germany) Petra Czugler+49 69 45009 Sign in to access your portfolio
Yahoo
30-01-2025
- Business
- Yahoo
Medical Properties Trust Announces Pricing of $1.5 Billion 8.500% Senior Secured Notes Due 2032 and €1.0 Billion 7.000% Senior Secured Notes Due 2032
Pricing Represents a Blended Coupon of 7.885% BIRMINGHAM, Ala., January 31, 2025--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the "Company" or "MPT") (NYSE: MPW) today announced the pricing of the private offering of $1.5 billion in aggregate principal amount of senior secured notes due 2032 (the "USD Notes") and €1.0 billion aggregate principal amount of senior secured notes due 2032 (the "Euro Notes" and together with the USD Notes, the "Notes") to be issued by its operating partnership, MPT Operating Partnership, L.P., and MPT Finance Corporation, a wholly-owned subsidiary of the operating partnership (together, the "Issuers"). The offering sizes of the USD Notes and the Euro Notes were revised from the previously announced offering sizes of $2.0 billion and €500 million. The USD Notes priced with a coupon of 8.500% and the Euro Notes priced with a coupon of 7.000%, representing a blended coupon of 7.885%. Interest on the Notes will be payable semi-annually in arrears on February 15 and August 15 of each year, commencing on August 15, 2025, and will mature on February 15, 2032. The offering is expected to close on February 13, 2025, subject to customary closing conditions. The Issuers estimate that the net proceeds from the offering of the USD Notes will be approximately $1.46 billion and that the net proceeds from the offering of the Euro Notes will be approximately €974 million, in each case, after deducting discounts and commissions to the initial purchasers but before deducting offering related expenses. The Issuers intend to use a portion of the net proceeds of the Notes to fund the redemption in full of the Issuers' 3.325% senior notes due 2025, 2.500% senior notes due 2026 and 5.250% senior notes due 2026, including related accrued interest, fees and expenses. The Issuers intend to use the remaining net proceeds, estimated to be approximately $0.8 billion, for general corporate purposes, which may include repaying other indebtedness, including amounts outstanding from time-to-time under the Company's revolving credit facility, working capital, capital expenditures and potential future acquisitions. The Notes will be fully and unconditionally guaranteed, on a joint and several basis by the Company and its collateral-owning subsidiaries, in addition to any other subsidiaries that are guarantors under the Company's senior credit facilities and any U.S. domestic restricted subsidiaries that in the future borrow under or guarantee borrowings under the Company's senior credit facilities. The Notes and the guarantees thereof will be secured by first-priority liens on equity of the Company's subsidiaries that, as of the date hereof, directly own or ground lease a diversified pool of 167 properties with 19 different operators in the U.S., U.K. and Germany. Concurrent with closing the Notes, the Company expects to enter into an amendment to its senior revolving credit and term loan agreement to cause the senior revolving credit facility and senior term loan facility to share in the collateral and guarantees on a pro rata basis and to make certain other amendments with respect to the financial covenants. The offering of the Notes and the related guarantees was and will be made in a private transaction in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), in the United States only to persons reasonably believed to be "qualified institutional buyers," as that term is defined in Rule 144A under the Securities Act, or outside the United States pursuant to Regulation S under the Securities Act. The Notes and the related guarantees have not been registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. This notice is being issued pursuant to and in accordance with Rule 135c under the Securities Act. About Medical Properties Trust, Inc. Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 402 facilities and approximately 40,000 licensed beds in nine countries and across three continents as of September 30, 2024. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. Forward-Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as "may", "will", "would", "could", "expect", "intend", "plan", "estimate", "target", "anticipate", "believe", "objectives", "outlook", "guidance" or other similar words, and include statements regarding our strategies, objectives, asset sales and other liquidity transactions (including the use of proceeds thereof), expected re-tenanting of facilities and any related regulatory approvals, and expected outcomes from Prospect's Chapter 11 restructuring process. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) our ability to successfully consummate the senior notes offering described in this press release, on the terms described herein or at all; (ii) the risk that the outcome and terms of the bankruptcy restructuring of Prospect will not be consistent with those anticipated by the Company; (iii) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (iv) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (v) MPT's ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact its ability to pay down, refinance, restructure or extend its indebtedness as it becomes due, or pursue acquisition and development opportunities; (vi) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us; (vii) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (viii) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all, (ix) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; and (x) the risks and uncertainties of litigation or other regulatory proceedings. The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned "Risk Factors" in our most recent Annual Report on Form 10-K and our Form 10-Q, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned to not place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made. View source version on Contacts Drew Babin, CFA, CMAHead of Financial Strategy and Investor RelationsMedical Properties Trust, Inc.(646) 884-9809dbabin@
